|Bid||10.18 x 1300|
|Ask||10.20 x 3000|
|Day's range||10.00 - 10.49|
|52-week range||8.39 - 76.99|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||15 Nov 2021 - 19 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
A look at the shareholders of NRx Pharmaceuticals, Inc. ( NASDAQ:NRXP ) can tell us which group is most powerful...
--Company to Host Conference Call August 17, 2021 at 8:30AM ET-- RADNOR, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals (NRx) (Nasdaq: NRXP), a clinical stage, global biopharmaceutical company, today announced that management will report second quarter 2021 financial results after the market close on August 16, 2021. The company will host a conference call and webcast on August 17, 2021, 8:30 AM Eastern Time to discuss its results and provide a clinical and corporate update. Manageme
Dr. Steven Corwin, NewYork Presbyterian Hospital CEO, joins Yahoo Finance Live to discuss the latest on the coronavirus pandemic.